補充問答

臨床試驗中的統計學考量 會後問答 補充問答

有關其他沒有在影片中回覆的問題,答覆如下:

有關Non-inferiority臨床試驗的參考書

A:請參閱


How should I design a biostatistic model for the treatment of the lung cancer if this novel treatment will benefit the victims with the stage IV by changing their natural courses to the stage I?

A: I am not familiar with the treatment changing the natural course of stage IV lung cancer to the stage I, so I am sorry for not being able to offer you any suggestion.

喜歡我們的內容嗎?

現在訂閱臨床資訊知識報
RICCI 帶你跟上臨床試驗數位轉型最新趨勢
歡迎來到 RICCI!
還不是會員嗎?點此註冊